A carregar...
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial
INTRODUCTION—Erythromycin, a motilin agonist, is a potent prokinetic. ABT-229 is a specific motilin agonist that dose dependently accelerates gastric emptying. Dyspepsia and gastroparesis are common problems in type 1 diabetes mellitus. We aimed to evaluate the efficacy of ABT-229 in symptomatic dia...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1728418/ https://ncbi.nlm.nih.gov/pubmed/11511562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.49.3.395 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|